Transcend Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-418	Closed	-$302K	–	514
2022 Q4	$302K	Buy	418 +114	+38%	+$82.3K	0.03%	361
2022 Q3	$209K	Buy	+304	New	+$209K	0.02%	437
2020 Q2	–	Sell	-467	Closed	-$239K	–	179
2020 Q1	$239K	Buy	+467	New	+$239K	0.07%	180